Latest Brain tumor Stories
- Data supports potential to address a significant unmet need as a therapeutic option for temozolomide-resistant GBM - VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/
- End of Dose-Escalation Confirmed - VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar
DCVax-L and DCVax-Direct Both To Be the Subject of Presentations Today BETHESDA, Md., April 20, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
CALGARY, April 17, 2015 /PRNewswire/ - Oncolytics Biotech Inc.
Technique allows surgeons to perform minimally invasive brain surgery NORFOLK, Va., April 16, 2015 /PRNewswire-iReach/ -- Bon Secours DePaul Medical Center announced today that neurosurgeons
CALGARY, April 15, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.
DETROIT, April 13, 2015 /PRNewswire/ -- The 2015 Henry Ford Brain Tumor Symposium takes place 8 a.m. - 5 p.m.
Scientists have discovered a small RNA molecule known as miR-182 that can curb cancer-causing genes in mice with a deadly and incurable kind of brain tumor, glioblastoma mulitforme (GBM), according to a new study published in the journal Genes & Development.
LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015" provides data on the
- Growing in low tufty patches.